It sounds too good to be true, but a novel approach that might allow you to eat as much as you want without gaining weight could be a reality in the near future.
When a single gene known as RCAN1 was removed in mice and they were fed, they failed to gain weight, even after gorging on high-fat foods for prolonged periods.
The international team, led by Associate Professor Beverly Rothermel at the University of Texas Southwestern Medical Center and Professor Damien Keating at Flinders University, are hopeful a similar approach that inhibits this gene will also be effective with humans to combat obesity and serious diseases like diabetes.
The study used a large genetic screen in rodents to identify novel genetic candidates that may cause obesity, potentially paving the way for new drug therapies.
“We know a lot of people struggle to lose weight or even control their weight for a number of different reasons,” says Professor Keating, from the Molecular and Cellular Physiology Laboratory at the College of Medicine and Public Health at Flinders.
“The findings in this study could mean developing a pill which would target the function of RCAN1 and may result in weight loss,” he says.
Obesity is a major global health epidemic, resulting in increased risk of serious diseases like type 2 diabetes, and heart disease, but avenues for effective therapeutic treatments are lacking.
There are two types of fat in the human body – brown fat burns energy, while white fat stores energy.
Professor Keating says blocking RCAN1 helps to transform unhealthy white fat into healthy brown fat, presenting a potential treatment method in the fight against obesity.
“We have already developed a series of drugs that target the protein that this gene makes, and we are now in the process of testing them to see if they inhibit RCAN1 and whether they might represent potential new anti-obesity drugs,” he says.
“In light of our results, the drugs we are developing to target RCAN1 would burn more calories while people are resting.
“It means the body would store less fat without the need for a person to reduce food consumption or exercise more.”
Two-thirds of Australian adults and a quarter of children are either overweight or obese, and the statistics are just as concerning in Britain and the US.
“Co-investigators in the research, Dr David Rotter and Heshan Peiris, looked at a variety of different diets with various timespans from eight weeks up to six months, and in every case we saw health improvements in the absence of the RCAN1 gene,” says Professor Keating, an NHMRC Principal Research Fellow at the Centre for Neuroscience at Flinders University.
The researchers say these findings open up a potentially simple treatment but further studies are required to determine if they translate the same results to humans.
“Our research is focused on understanding how cells send signals to each other and how this impacts health and the spread of disease”.
“We really want to pursue this, it’s exciting and we have research funding from the Australian government through the National Health and Medical Research Council (NHMRC) to continue to explore viable options.
“These results show we can potentially make a real difference in the fight again obesity.”
Learn more: Gene discovery holds promise against obesity
The Latest on: Obesity
via Google News
The Latest on: Obesity
- Too much TV time 'is the biggest driver of childhood obesity'on December 11, 2019 at 4:08 pm
Too much TV time may be the biggest driver of childhood obesity, research suggests. Scientists from the Barcelona Institute for Global Health set out to uncover the lifestyle habits that cause ...
- Exercise advice on food labels could help reduce obesity, researchers sayon December 11, 2019 at 7:39 am
Food labels detailing how much exercise is needed to burn off a product's calorie content could help to combat obesity, according to UK researchers. Physical activity calorie equivalent (PACE) labels ...
- Anti-Obesity Drugs Market strategic analysis and Industry Forecast till 2026on December 10, 2019 at 11:24 pm
Dec 11, 2019 (Heraldkeepers) -- Anti-obesity drugs are pharmacological products which are consumed to control or reduce the weight of the obese people by absorbing calories of dipping the hunger. Some ...
- Exercise advice on food labels could help to tackle the obesity crisison December 10, 2019 at 3:30 pm
Saying how far consumers would need to walk to burn off the calories they’d eaten could motivate them ...
- Brain differences may be tied to obesity, kids' study sayson December 10, 2019 at 10:57 am
New results from the largest long-term study of brain development and children’s health raise provocative questions about obesity and brain function. Does excess body weight somehow reduce brain ...
- Obesity inequality gap grows for Scottish childrenon December 10, 2019 at 6:21 am
The obesity inequality gap among Scottish schoolchildren is continuing to grow, new figures show. Almost a quarter of children in Scotland are starting school at risk of being overweight or obese. The ...
- Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodelingon December 10, 2019 at 2:30 am
Attenuating myeloperoxidase (MPO) activity, an inflammatory enzyme associated with obesity, hypertension and heart failure, could have protective effects on multiple organs. Herein, the effects of the ...
- The association of Dietary Approach to Stop Hypertension (DASH) diet with metabolic healthy and metabolic unhealthy obesity phenotypeson December 10, 2019 at 2:19 am
The current study aimed at investigating the association between Dietary Approach to Stop Hypertension (DASH) diet and odds of obesity phenotypes, is a cross sectional study conducted on 3218 Iranian ...
- C-Section Is Not Tied to Obesity in Childrenon December 10, 2019 at 2:00 am
Some recent reports have suggested that women who give birth by cesarean section are more likely to have obese children. But a large new study found no link between the method of birth and obesity.
- Federal Courts Have Diminishing Appetite For Claims Of Obesity Discriminationon December 9, 2019 at 7:54 pm
Four federal circuits now have ruled that obesity is not a qualified impairment under the ADA unless it is shown to be the result of an underlying “physiological disorder or condition.” No federal ...
via Bing News